EQT Fund Management S.a r.l.

CIK 0001834239 · Q1 2026

13F Equity AUM

$1.0B

-8.2% QoQ

Positions

+1 QoQ

AUM Rank

#2,756

Top 22%

Skill Alpha (FF)

—

Building track record (3q)

Quarters Tracked

~2 years

Portfolio Concentration

Top 5: 100.0%Top 10: 100.0%Top 20: 100.0%

WAY58.8%

OCSAW15.4%

EVMN11.1%

PHVS9.5%

AGOMAB THERAPEUTICS NV5.3%

HHI (Herfindahl-Hirschman Index) measures portfolio concentration. Low (<1500) = diversified, Moderate (1500-2500), High (>2500) = concentrated bets.

Sector Allocation

Technology58.8%

Unclassified20.6%

Healthcare20.6%

Portfolio weight by GICS sector based on latest 13F filing. Sectors below 2% are grouped as “Other.”

Position Sizing

Positions: 5Median: 11.10%Avg: 20.00%

0–0.5%

0(0.0%)

0.5–1%

0(0.0%)

1–3%

0(0.0%)

3–5%

0(0.0%)

5%+

5(100.0%)

Count of positions per weight bucket — (%) = combined portfolio weight

Loading summary cards...

Portfolio Overlap

Shared: 5Unique: 0vs 20 funds

0.1%Low

Fund positions

7,299

Consensus CUSIPs

Jaccard similarity of this fund’s portfolio vs the consensus of top 20 funds by AUM. Low (<15%) = contrarian, Moderate (15-40%), High (>40%) = follows the crowd.

Most Similar Funds

Top 9 benchmark funds with highest portfolio overlap (Jaccard similarity)

GEODE CAPITAL MANAGEMENT, LLC

0.1%

0.1%

0.1%

0.1%

0.1%

0.1%

BANK OF AMERICA CORP /DE/

0.1%

VANGUARD CAPITAL MANAGEMENT LLC

0.1%

VANGUARD PORTFOLIO MANAGEMENT LLC

0.1%

Jaccard similarity per fund: shared CUSIPs / (fund A + fund B − shared). Higher values indicate more similar portfolios.

Loading overlap analysis...

Position Changes This Quarter

New1Increased0Decreased0Exited0

New Positions

AGOMAB THERAPEUTICS …5.3%

+5.1M

Quarter-over-quarter changes compared to prior 13F filing. New = first appearance; Exited = no longer held.

Loading position changes...

Holdings

Loading holdings...